Skip to main content
NXXT
NASDAQ Trade & Services

NextNRG Finalizes Reverse Split, $30M Toxic Financing, and Massive CEO Pay Package

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Software Stocks · Technology
Sentiment info
Negative
Importance info
8
Price
$0.233
Mkt Cap
$39.263M
52W Low
$0.203
52W High
$2.88
52W Position info
15% above low
Off High info
92% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

NXXT is trading near its 52-week low of $0.203 (15% above the low) on light trading volume (0.2× avg).

Summary

NextNRG's definitive 14C makes effective a reverse stock split, a $30M toxic preferred financing with a $0.135 floor price, and a CEO pay package that could grant Michael Farkas up to 10% of the company at market cap milestones. The initial $9.2M financing tranche already closed.


Key Events · Corporate Governance and Compliance · NXXT

  • Reverse Stock Split Approved

    Board authorized a 1-for-5 to 1-for-12 reverse split to regain Nasdaq's $1.00 minimum bid price. Company received delisting notice on March 16, 2026, with compliance deadline September 14, 2026.

  • Series C Financing Initial Closing

    On August 13, 2026, NextNRG issued 1,000,000 Series C Preferred Shares for $9.2 million. The shares convert at $0.75 initially, with a floor price of $0.135, potentially creating up to 74,074,074 common shares (30.6% dilution).

  • CEO Compensation Package

    Michael Farkas' employment agreement includes $720,000 base salary, $2,000,000 annual equity salary, and market cap bonuses of 10% of outstanding shares at $500M, $1B, $2B, $4B, and $8B thresholds. Signing bonus is $8,160,000 in restricted stock.

  • Equity Plan Expansion

    2023 Equity Incentive Plan shares increased by 32,000,000 to 54,250,000, a 144% increase, to accommodate the CEO's equity awards and other grants.


Analysis · NXXT · Trade & Services

This definitive information statement makes effective a package of highly dilutive and governance-heavy actions: a reverse stock split to avoid Nasdaq delisting, a $30 million Series C preferred financing with a $0.135 floor price that could dilute existing holders by over 30%, and an employment agreement granting CEO Michael Farkas up to 10% of the company's shares at various market cap milestones. The initial $9.2 million tranche of the toxic financing already closed on August 13, 2026, and the company remains under going-concern warning with critically low cash. The CEO's compensation package is unusually aggressive for a company of this size and financial condition, and the reverse split is a last-ditch effort to maintain Nasdaq listing.

At the time of this filing, NXXT was trading at $0.23 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $39.3M. The 52-week trading range was $0.20 to $2.88. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

NXXT - Latest Insights

NXXT
Aug 13, 2026, 4:02 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.3219
Real-time Price: $0.2331 info
Change: -$0.0888 (-28%) info
Market Cap: $39.263M info
NXXT
Aug 07, 2026, 6:54 PM EDT
Filing Type: PRER14C
Importance Score:
9
Price at Filing: $0.283
Real-time Price: $0.2331 info
Change: -$0.0499 (-18%) info
Market Cap: $39.263M info
NXXT
Jul 31, 2026, 5:29 PM EDT
Filing Type: PRE 14C
Importance Score:
9
Price at Filing: $0.255
Real-time Price: $0.2331 info
Change: -$0.0219 (-9%) info
Market Cap: $39.263M info
NXXT
Jul 29, 2026, 5:00 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.260
Real-time Price: $0.2331 info
Change: -$0.0269 (-10%) info
Market Cap: $39.263M info
NXXT
Jul 07, 2026, 4:45 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.3421
Real-time Price: $0.2331 info
Change: -$0.109 (-32%) info
Market Cap: $39.263M info